Your browser doesn't support javascript.
loading
Metformin and ß-cell function in insulin-treated patients with type 2 diabetes: A randomized placebo-controlled 4.3-year trial.
Top, Wiebe; Stehouwer, Coen; Lehert, Philippe; Kooy, Adriaan.
Affiliation
  • Top W; Care Group Treant, Location Bethesda, Internal Medicine, Hoogeveen, The Netherlands.
  • Stehouwer C; MUMC, Internal Medicine, Maastricht, The Netherlands.
  • Lehert P; Faculty of Economics, University of Louvain, Mons, Belgium.
  • Kooy A; Care Group Treant, Location Bethesda, Internal Medicine, Hoogeveen, The Netherlands.
Diabetes Obes Metab ; 20(3): 730-733, 2018 03.
Article in En | MEDLINE | ID: mdl-28967181
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Insulin-Secreting Cells / Hypoglycemic Agents / Insulin / Metformin Type of study: Clinical_trials Limits: Humans Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2018 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Insulin-Secreting Cells / Hypoglycemic Agents / Insulin / Metformin Type of study: Clinical_trials Limits: Humans Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2018 Document type: Article Affiliation country: